Welcome to Pharma Disclosure

This website has been developed as a joint initiative between the European Federation of Pharmaceutical Industries and Associations (EFPIA) and VitalTransformation.com to highlight the industry’s new rules on disclosing financial relationships with doctors and healthcare organisations, follow progress in the implementation and to monitor compliance in the 33 countries involved in the initiative  …Read more

Events

  • EVENT – Going Live: Implementation of the Disclosure Code

EVENT – Going Live: Implementation of the Disclosure Code

January 29th 2015 - Hilton, Rotterdam - 9.30-13.15

This event is part of EFPIA's Responsible Transparency initiative, a public information campaign launched to boost pharmaceutical industry preparedness with complying to new disclosure rules for certain financial and other transfers of value with healthcare professionals and organisations. This event will inform the public on the progress of disclosure on a European and member state level.
  • WEBINAR: The EFPIA Code  “Moving The Industry/Health Care Professional Partnership Forward”

WEBINAR: The EFPIA Code “Moving The Industry/Health Care Professional Partnership Forward”

September 16th, 12:30 - 14:00 CET (11:30 - 13:00 UK)

In preparation for the implementation of The EFPIA Code outlining the disclosure of transfers of value to healthcare professionals, this webinar is an opportunity to discuss the relationship between practitioners and industry, and how improved transparency will ultimately lead to greater trust and improved patient outcomes.

Lastest News

  • Leading Polish Physician Expresses Doubts About Financial Transparency

Leading Polish Physician Expresses Doubts About Financial Transparency

  • December 18th, 2014

By Zbigniew Gaciong


Implementing EFPIA’s code on transfers of value involves an inequitable level of disclosure by individual doctors and will leave members of the medical profession in Poland open to media sensation, says Zbigniew Gaciong, Chairman of the Department of Internal Medicine, Hypertension and Vascular Diseases at the Medical University of Warsaw
  • Ensure the Benefits of Financial Transparency are Properly Understood

Ensure the Benefits of Financial Transparency are Properly Understood

  • December 18th, 2014

By Athanasios Exadaktylos


While financial transparency will have an important long term impact, there is potential for misunderstanding of the initiative in the short term, believes Athanasios Exadaktylos, Chairman of Thessaloniki Medical Chamber. It is essential to explain the benefits, Dr Exadaktylos says in this Q&A with pharmadisclosure.eu
  • Moving to Implementation: Accurate and Complete Data Helps Patients and Defuses Hype

Moving to Implementation: Accurate and Complete Data Helps Patients and Defuses Hype

  • December 18th, 2014

by Lode Wigersma


While there is understandable concern in the medical profession that financial disclosure will fuel media sensation, the Dutch experience indicates that showing exactly how much was paid to who, for what, neutralises speculation, says Lode Wigersma, former director of the Royal Dutch Medical Association
  • Disclosure update from Ireland

Disclosure update from Ireland

  • December 12th, 2014

By Gary Finnegan

Pharmaceutical firms will publish details of "transfers of value" to health professionals as part of a new industry-wide transparency drive for the first time in 2016.